Madrigal Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (19)

View All

Latest Posts

About This Stock More About This Stock
Earnings Optimism Puts Wind In Wall Street's Sails
Article By: Schaeffers Research
Wednesday, December 21, 2022 12:37 PM EDT
The major indexes are extending their rally off a mid-December losing streak.
In this article: QQQ, LIPO, SPX, VIX, DJI, MDGL, SINT
Read
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro
Article By: Rod Raynovich
Monday, December 19, 2022 6:35 PM EDT
The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning.
In this article: LLY, MRK, UNH, IBB, REGN, GILD, VRTX, XBI, ABBV, MDGL
Read
Dow Struggles To Maintain Morning Gains
Article By: Schaeffers Research
Monday, December 19, 2022 12:26 PM EDT
This morning's rally was short-lived, and by midday, the major indexes were trading back in the red amid looming recession anxieties.
In this article: QQQ, SPX, VIX, DJI, NH, MDGL, LI
Read
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Article By: Rod Raynovich
Wednesday, June 22, 2022 5:36 AM EDT
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma.
In this article: LLY, UNH, XLV, CRSP Also: CCXI, EVH, MRTX, MDGL, VCYT
Read
Tough Slogging Ahead For Investors, Diversification Is Important
Article By: Rod Raynovich
Monday, March 7, 2022 2:13 PM EDT
Speculative small/mid-cap biotech stocks hit new lows this past week with the XBI at a “triple bottom” about the $84 level only 10 points above the March 2020 lows.
In this article: XBI, XLE, XLV Also: LGND, SGEN, SRPT, EVH, CRSP, MDGL
Read
All Posts

Latest Tweets for $MDGL

No tweets yet!

PARTNER HEADLINES